尊敬的各位同仁,

为了繁荣中美肝病学术交流,及时了解国际肝病学术最新进展,提高我国肝病防治技术水 平,中国肝炎防治基金会与美国肝病学会联合发起了“中美肝病学院”项目。

会议邀请了20余名中美两国一流专家为中国肝病医生讲授美国肝病年会最新研究成果和我 国肝病临床实践新进展。内容涵盖乙型肝炎、丙型肝炎、肝细胞肝癌、非酒精性脂肪性肝病、 肝硬化和肝移植、酒精性肝病、自身免疫性肝病、肝衰竭等领域。届时将有约1600名来自全国 各地的医生出席此次盛会。

中国肝炎防治基金会多年来一直致力于通过动员卫生部门、医学专家、医药企业等社会资 源,为推动肝炎防治事业的发展和学术进步搭建平台。会议期间,将为相关领域企业提供展示 企业形象,宣传新技术新产品的机会。作为中国主办方,我们诚邀各友好企业参加和赞助本次 大会,共同为中国的肝病防治事业作出积极贡献!



杨希忠 教授
中国肝炎防治基金会副理事长兼秘书长
大会中方主席
Dear Colleagues,

It is with great pleasure that the American Association for the Study of Liver Diseases (AASLD) and the Chinese Foundation for Hepatitis Prevention and Control (CFHPC) together, announce we are planning an inaugural joint conference to CONNECT physicians and health care providers in China with experts from the USA and China in the area of hepatology. We recognize many physicians in China are interested in cutting edge research findings presented at The Liver Meeting®, but only a few can make it to the meeting. We are enthusiastic to have the opportunity to partner with CFHPC to share these exciting data with our colleagues in China. We expect many physicians in China will want to participate at this meeting and learn about the latest liver disease research and AASLD guideline recommendations, discuss treatment approaches, and interact with colleagues at this must-attend event in the science and practice of hepatology.

AASLD is the global leader focused on advancing the science and practice of hepatology. Content delivered from our programs and journals, combined with local perspectives from experts in China, will facilitate the incorporation of cutting edge research data into practice and offer the best possible atmosphere to encourage collaborative research between Chinese and American physicians.

We look forward to meeting many of our colleagues in China and to foster collaboration.

Sincerely



Anna S. Lok, MD, FAASLD
大会美方主席, AASLD